Volume 63, Issue 5, Pages (May 2003)

Slides:



Advertisements
Similar presentations
Renal involvement in hepatitis C infection: Cryoglobulinemic glomerulonephritis Giuseppe D’Amico Kidney International Volume 54, Issue 2, Pages
Advertisements

Renal Stress Testing in the Assessment of Kidney Disease Lakhmir S. Chawla, Claudio Ronco Kidney International Reports Volume 1, Issue 1, Pages (May.
Frederik Persson, Peter Rossing  Kidney International Supplements 
Mitchell H. Rosner, W. Kline Bolton  Kidney International 
No difference in bleeding risk between subcutaneous enoxaparin and heparin for thromboprophylaxis in end-stage renal disease  Kevin E. Chan, Ravi I. Thadhani,
Volume 83, Issue 3, Pages (March 2013)
Kidney transplantation in a low-resource setting: Nigeria experience
Volume 61, Issue 2, Pages (February 2002)
Mortality caused by sepsis in patients with end-stage renal disease compared with the general population  Mark J. Sarnak, Bertrand L. Jaber  Kidney International 
Burden of chronic kidney disease: North Africa
Smoking and cardiovascular outcomes in dialysis patients: The United States Renal Data System Wave 2 Study1,2  Robert N. Foley, Charles A. Herzog, Allan.
Francesco Paolo Schena  Kidney International 
Need for better diabetes treatment for improved renal outcome
Volume 63, Issue 3, Pages (March 2003)
End-stage renal disease in living kidney donors
Volume 72, Issue 9, Pages (November 2007)
Anemia as a risk factor for chronic kidney disease
Comorbidity and confounding in end-stage renal disease
Volume 70, Issue 11, Pages (December 2006)
Volume 55, Issue 3, Pages (March 1999)
Edmund G. Lowrie  Kidney International 
Acute myocardial infarction in patients with end-stage renal disease
Volume 71, Issue 6, Pages (March 2007)
Volume 70, Issue 12, Pages (December 2006)
Volume 85, Issue 6, Pages (June 2014)
Volume 67, Pages S48-S51 (January 2005)
Volume 65, Issue 6, Pages (June 2004)
Volume 76, Issue 5, Pages (September 2009)
Fructose intake as a risk factor for kidney stone disease
Volume 73, Issue 12, Pages (June 2008)
Volume 57, Issue 1, Pages (January 2000)
Extracorporeal therapy in sepsis: are we there yet?
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Elevated risk of stroke among patients with end-stage renal disease
Volume 74, Issue 8, Pages (October 2008)
Alternate-day dialysis may be needed for hemodialysis patients
Atrial fibrillation in end-stage renal disease: an emerging problem
The global challenge of chronic kidney disease
V.R. Sørensen, P.M. Hansen, J. Heaf, B. Feldt-Rasmussen 
Lynda Anne Szczech, Ira L. Lazar  Kidney International 
A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease  S. Susan Hedayati, Venkata Yalamanchili,
Higher serum C-reactive protein predicts short and long-term outcomes in peritoneal dialysis-associated peritonitis  N.-Y. Zalunardo, C.-L. Rose, I.W.Y.
Volume 81, Issue 9, Pages (May 2012)
Prehypertension: is it relevant for nephrologists?
Volume 58, Issue 5, Pages (November 2000)
Volume 70, Issue 3, Pages (August 2006)
Volume 64, Issue 2, Pages (August 2003)
Volume 81, Issue 12, Pages (June 2012)
Clinical renoprotection trials involving angiotensin II-receptor antagonists and angiotensin-converting-enzyme inhibitors  Barry M. Brenner, Joann Zagrobelny 
Unraveling the racial disparities associated with kidney disease1
Peritoneal dialysis in Mexico
Clinical benefits of slowing the progression of renal failure
Volume 76, Issue 6, Pages (September 2009)
The Danish Renal Biopsy Register
Volume 80, Issue 10, Pages (November 2011)
Is it the low-protein diet or simply the salt restriction?
Volume 68, Pages S87-S94 (August 2005)
Charles A. Herzog  Kidney International 
Is complement a target for therapy in renal disease?
Giuseppe Remuzzi, Carlos Chiurchiu, Piero Ruggenenti 
H.J. Chin, H. Ro, H.J. Lee, K.Y. Na, D.-W. Chae  Kidney International 
Volume 75, Issue 7, Pages (April 2009)
Membranous nephropathy: recent travels and new roads ahead
Volume 72, Issue 11, Pages (December 2007)
Volume 70, Issue 10, Pages (November 2006)
Volume 53, Issue 5, Pages (May 1998)
Prediction in idiopathic membranous nephropathy
Stephen Pastan, J. Michael Soucie, William M. McClellan 
Plasma concentration and urinary excretion of N-terminal proatrial natriuretic peptides in patients with kidney diseases  Martina Franz, Wolfgang Woloszczuk,
Presentation transcript:

Volume 63, Issue 5, Pages 1924-1933 (May 2003) Predicting end-stage renal disease: Bayesian perspective of information transfer in the clinical decision-making process at the individual level  Borislav D. Dimitrov, Annalisa Perna, Piero Ruggenenti, Giuseppe Remuzzi  Kidney International  Volume 63, Issue 5, Pages 1924-1933 (May 2003) DOI: 10.1046/j.1523-1755.2003.00923.x Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 1 Simple decision tree model of the risk of occurrence of end-stage renal disease (ESRD) in average United States patient when the increased level of proteinuria is considered as a risk factor. Simple decision tree with ESRD as an outcome with two levels (Yes and No) and proteinuria as a (risk) factor with two levels (Present, a risk factor level when urinary protein ≥3g/day; Absent, no-risk factor level when urinary protein <3g/day). The related a priori assumptions and probabilities on branches and nodes of the tree are shown: (1) a priori information (e.g., ESRD prevalence rate as an a priori probability of 0.001156, at the root chance node) and (2) decisional probabilities include posterior probabilities (i.e., individual probabilities or risk when expressed in percentages, at the branches) and path probabilities (i.e., the chance of reaching a node, as probability “P,” shown here only on the right side of the terminal nodes). Symbols are: (•) chance nodes; (♦) terminal nodes. Kidney International 2003 63, 1924-1933DOI: (10.1046/j.1523-1755.2003.00923.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 2 Parallel decision tree model of the risk of occurrence of end-stage renal disease (ESRD) in average United States patient when two risk factors are considered. Multifactorial decision tree model with parallel consideration of information on risk factors (i.e., four combinations of the factor levels) and computation of posterior probabilities (branches, terminal nodes). Symbols are: (•) chance nodes; (♦) terminal nodes. For other attributes see descriptions and definitions on Figure 1. Kidney International 2003 63, 1924-1933DOI: (10.1046/j.1523-1755.2003.00923.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 3 Sequential decision tree model of the risk of occurrence of end-stage renal disease (ESRD) in average United States patient when two risk factors are considered. Multifactorial decision tree model with sequential (consecutive) input of information on risk factors and computation of posterior probabilities (branches, terminal nodes). Symbols are: (•) chance nodes; (♦) terminal nodes. For other attributes see descriptions and definitions on Figure 1. Kidney International 2003 63, 1924-1933DOI: (10.1046/j.1523-1755.2003.00923.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 4 Intersection diagram of clinical decision-making process (reproduced with permission from43). Kidney International 2003 63, 1924-1933DOI: (10.1046/j.1523-1755.2003.00923.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 5 Flow-diagram of a “frequentist” approach to problem decision (from50 with modifications). (A) Theoretical example; (B) REIN study example. Kidney International 2003 63, 1924-1933DOI: (10.1046/j.1523-1755.2003.00923.x) Copyright © 2003 International Society of Nephrology Terms and Conditions